Skip to main navigation Skip to search Skip to main content

Lupus anticoagulant-hypoprothrombinemia syndrome and catastrophic antiphospholipid syndrome in a patient with antidomain I antibodies

  • Joris Galland*
  • , Shirine Mohamed
  • , Sabine Revuz
  • , Emmanuel de Maistre
  • , Bas de Laat
  • , Pierre-Yves Marie
  • , Stephane Zuily
  • , Bruno Levy
  • , Veronique Regnault
  • , Denis Wahl
  • *Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

Abstract

Lupus anticoagulant-hypoprothrombinemia syndrome is a rare condition characterized by the association of acquired factor II deficiency and lupus anticoagulant. Contrary to classical antiphospholipid syndrome, it may cause severe life-threatening bleeding (89% of published cases). We report a patient, positive for antidomain I antibodies, with initially primary lupus anticoagulant-hypoprothrombinemia syndrome without previous clinical manifestation or underlying systemic disease. Five years later, he experienced the first systemic lupus erythematous flare. Within a few days, catastrophic antiphospholipid syndrome was diagnosed with heart, liver and kidney involvement. The patient recovered under pulse steroids, intravenous heparin and intravenous immunoglobulins.
Original languageEnglish
Pages (from-to)580-582
Number of pages3
JournalBlood Coagulation & Fibrinolysis
Volume27
Issue number5
DOIs
Publication statusPublished - Jul 2016

Keywords

  • antidomain I antibodies
  • catastrophic antiphospholipid antibody syndrome
  • lupus anticoagulant-hypoprothrombinemia syndrome
  • systemic lupus erythematosus

Fingerprint

Dive into the research topics of 'Lupus anticoagulant-hypoprothrombinemia syndrome and catastrophic antiphospholipid syndrome in a patient with antidomain I antibodies'. Together they form a unique fingerprint.

Cite this